title: Hypercomplementaemia as a marker of the evolution from benign to malignant B cell proliferation in patients with type II mixed cryoglobulinaemia.
authors.forename: C
authors.initials: C
authors.lastname: Vitali
authors.forename: C
authors.initials: C
authors.lastname: Ferri
authors.forename: P
authors.initials: P
authors.lastname: Nasti
authors.forename: L
authors.initials: L
authors.lastname: La Civita
authors.forename: M
authors.initials: M
authors.lastname: Mazzantini
authors.forename: G
authors.initials: G
authors.lastname: Longombardo
authors.forename: S
authors.initials: S
authors.lastname: Bombardieri
mesh_terms: D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D003165:Complement System Proteins / Q000378:metabolism*; D003449:Cryoglobulinemia / Q000097:blood*; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood*; D016393:Lymphoma, B-Cell / Q000097:blood*; D008875:Middle Aged
chemical_list: D014408:Biomarkers, Tumor; D003165:Complement System Proteins